Metformin (generic), Glucophage Newswire (Page 3)

Metformin (generic), Glucophage Newswire (Page 3)

Comprehensive Real-Time News Feed for Metformin (generic), Glucophage. (Page 3)

Results 41 - 60 of 618 in Metformin (generic), Glucophage

  1. Merck Announces First-Quarter 2017 Financial ResultsRead the original story

    Tuesday May 2 | Customer Interaction Solutions

    Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2017. "Merck delivered solid performance across our broad range of products that address major disease categories and the needs of global health," said Kenneth C. Frazier, chairman and chief executive officer, Merck.

    Comment?

  2. Why Neurocrine is charging twice as much for its new drug as it said it wouldRead the original story w/Photo

    Tuesday May 2 | MarketWatch

    When Neurocrine Biosciences' drug Ingrezza was first approved last month, the company announced that the $64,000-a-year price tag would be "essentially the same" at different dose levels so patients could focus on their treatment, not on cost. But for the next five months, or maybe the rest of the year, patients taking Ingrezza's recommended dose will be paying twice as much as they're supposed to.

    Comment?

  3. Nevada bill for insulin reimbursements at a glanceRead the original story

    Monday May 1 | Washington Times

    A Nevada bill would force pharmaceutical drugmakers to refund insurance companies and diabetics if insulin prices rise above inflation, and require drugmakers to disclose information about costs associated with insulin. Insulin makers would have to disclose list prices and reimburse insurers and others who pay for diabetes-related drugs when insulin prices are higher than inflation.

    Comment?

  4. Cinnamic acid and diabetes: Clinical studies needed to assess bioavailability concernsRead the original story w/Photo

    Sunday Apr 30 | NutraIngredients

    Cinnamic acid's potential for diabetes management has been highlighted in a new review, but concerns over bioavailability are still hindering its use in nutraceuticals. Written by Sirichai Adisakwattana from the Department of Nutrition and Dietetics, Chulalongkorn University in Thailand, the review highlighted several in-vitro studies and animal models where cinnamic acid and its derivatives were used to help improve diabetes complications, including stimulation of insulin secretion, improvement of pancreatic-cell functionality, inhibition of hepatic gluconeogenesis, and enhanced glucose uptake.

    Comment?

  5. I've seen over 8,000 medical professionals. Here's what I've learned.Read the original story w/Photo

    Sunday Apr 30 | Kevin, M.D.

    Today, I am a 40-year old with type 2 diabetes. I have been on glyburide since I was diagnosed four years ago and am otherwise healthy, although my blood pressure today is 140/96.

    Comment?

  6. Insulin patch pump: A new tool for diabetes careRead the original story w/Photo

    Saturday Apr 29 | The Daily Star

    Type 2 diabetes is the most common type of diabetes in the world. T2D is typically treated with lifestyle changes, such as increased physical activity and improved diet, and the oral drug metformin.

    Comment?

  7. Infiniti Research expects rapid growth in global wearable patch marketRead the original story w/Photo

    Saturday Apr 29 | Medical News

    Healthcare and technological innovations are colliding as the use of wearable patches increases in the medical field. Wearable medical patches can improve the quality and efficiency of care and increase positive patient outcomes.

    Comment?

  8. Wearable Patches on Track to Replace Traditional Healthcare Devices, Says Infiniti ResearchRead the original story w/Photo

    Friday Apr 28 | Business Wire

    Wearable medical patches can improve the quality and efficiency of care and increase positive patient outcomes. Infiniti Research expects the global wearable patch market to grow at an extremely fast rate in the coming years.

    Comment?

  9. Cardiometabolic Disease Market: Industry Survey and Industry Outlook 2025Read the original story w/Photo

    Thursday Apr 27 | SBWire

    Global Cardiometabolic Disease Market: Snapshot The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years. The high incidence of type 2 diabetes mellitus due to changing lifestyles, genetic predisposition, and obesity have collectively increased the risk of cardiometabolic diseases amongst the global population.

    Comment?

  10. Metformin alters DNA methylation genome-wide via the H19/SAHH axisRead the original story

    Wednesday Apr 26 | Oncogene

    E-mail: [email protected] The molecular mechanisms underlying the antineoplastic properties of metformin, a first-line drug for type 2 diabetes, remain elusive. Here we report that metformin induces genome-wide alterations in DNA methylation by modulating the activity of S-adenosylhomocysteine hydrolase .

    Comment?

  11. One in 7 people in Nevada is living with diabetes, and the state is...Read the original story w/Photo

    Wednesday Apr 26 | Silicon Alley Insider

    One in 7 people in Nevada is living with diabetes, and the state is now pushing a new approach to tackle the cost of treatment The state of Nevada is taking a new approach to tackling the rising price of prescription drugs with a new bill. The bill, introduced in March by state Senator Yvanna Cancela, has already faced opposition from lobbyists and nonprofit patient groups that disagree with the bill's approach to reining in prescription drug spending.

    Comment?

  12. Metformin and Organic Cation Transporter InteractionsRead the original story

    Apr 24, 2017 | Pharmacy Times

    Metformin has been a first-line oral treatment for patients with type 2 diabetes for 20-plus years. It exists as a cation at physiological pH, a state that limits the permeability of metformin through lipid membranes, with the ability to inhibit hepatic glucose production dependent on the drug entering the hepatocytes.

    Comment?

  13. Ask The Doctors | Large Dose Of Vitamin B12 Can Provide Quick Burst Of EnergyRead the original story w/Photo

    Wednesday Apr 26 | Log Cabin Democrat

    Dear Doctor: I'm almost 90 years old and always tired. I took two capsules of 2,000 mcg vitamin B12 the other night, and felt stronger and not as tired.

    Comment?

  14. Metro MediSpa Helps Patients with Anti-Aging Using MetforminRead the original story w/Photo

    Tuesday Apr 25 | 24-7 Press Release

    Metro Medispa is a leading Anti-Aging Doctor in Wilmington North Carolina. Connie Odom, MD is a board certified physician specializing in weight loss and hormone replacement therapy.

    Comment?

  15. LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell...Read the original story

    Tuesday Apr 25 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. The LKB1 tumor suppressor is mutationally inactivated in aS1 420% of non-small cell lung cancers .

    Comment?

  16. Workings of protein hold keys to new cancer treatmentsRead the original story w/Photo

    Tuesday Apr 25 | PhysOrg Weblog

    Though cancer treatments have advanced somewhat in our time, the methods still commonly used on patients are very harsh. These include invasive surgeries and chemotherapy.

    Comment?

  17. How to Prevent Type 2 DiabetesRead the original story

    Tuesday Apr 25 | US News & World Report

    First, there are some risks for Type 2 diabetes that are out of your control. You're more likely to have diabetes if it's in your family history , for example, and people of certain races and ethnicities are more likely to develop it.

    Comment?

  18. In any situation, listening is always best. Doctors should remember that.Read the original story w/Photo

    Tuesday Apr 25 | Kevin, M.D.

    This kind of circumstance is my holy grail. It is the ultimate moment where I connect the dots.

    Comment?

  19. Automatic endpoint detection to support the systematic review processRead the original story

    Apr 24, 2017 | CiteULike

    Manual processes used in systematic reviews and comparative effectiveness studies are slow. We built a system to extract 3 facets from comparative sentences.

    Comment?

  20. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.Read the original story

    Apr 24, 2017 | CiteULike

    There is substantial uncertainty about optimal glycemic control in older adults with type 2 diabetes mellitus. Four large randomized clinical trials , ranging in size from 1791 to 11,440 patients, provide the majority of the evidence used to guide diabetes therapy.

    Comment?